Due to the lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.Updates regarding government operating status and resumption of normal operations can be found at http://www.usa.gov.
Notice Number: NOT-NS-10-002
Release Date: October 16, 2009
NIH Blueprint for Neuroscience Research (http://neuroscienceblueprint.nih.gov/) and its member institutes, offices, and centers:
The NIH Blueprint for Neuroscience Research (http://neuroscienceblueprint.nih.gov/)
intends to issue a Request for Applications (RFA) to solicit projects for the Blueprint Grand Challenge for New Drugs for Diseases and Disorders of the Nervous System. The goal is to support the development of new small molecule drugs that will transform the treatment of neurological, psychiatric, or other nervous system diseases or conditions. These awards will provide 1) funding to support biological testing of compounds during development and 2) access to technical, infrastructure, and advisory resources to enable investigators to translate promising lead small molecule compounds into drugs that have completed phase 1 clinical trials. Applicants to this RFA must have:
Resources to conduct drug development activities other than bioactivity testing will be provided to the successful applicants by the NIH Blueprint. These include medicinal chemistry optimization, pharmacology and toxicology testing and Phase 1 clinical testing. Successful applicants will retain ownership of the intellectual property for compounds they develop through this program.
This notice is being provided to allow potential applicants sufficient time to develop responsive projects and necessary collaborations. The RFA is expected to be published in the NIH Guide for Grants and Contracts in April 2010 with an anticipated receipt date in August 2010.
This RFA will use the U01 cooperative agreement mechanism.
APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Interested parties may contact:
Jill Heemskerk Ph.D.
National Institute of Neurological Disorders and Stroke
National Institutes of Health
6001 Executive Boulevard, Room 2229
Bethesda, MD 20892-9525
EXPRESS/COURIER: Rockville, MD 20852
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.